MAM-2201 (4′-methyl-AM-2201, 5″-fluoro-JWH-122) is a drug that presumably acts as a potent agonist for the cannabinoid receptors.MAM-2201,eam-2201,how to make am-2201,am-2201 liquid,am-2201 legal status,am-2201 effects
It had never previously been reported in the scientific or patent literature, and was first identified by laboratories in the Netherlands and Germany in June 2011 as an ingredient in synthetic cannabis smoking blends.
Like RCS-4 and AB-001, MAM-2201 thus appears to be a novel compound invented by “research chemical” suppliers specifically for grey-market recreational use.
Structurally, MAM-2201 is a hybrid of two known cannabinoid compounds JWH-122 and AM-2201, both of which had previously been used as active ingredients in synthetic cannabis blends before being banned in many countries.
A study of MAM-2201 in rats showed that it causes neurofunctional disruptions.
This product has been manufactured and tested to meet ISO17025:2005 and Guide 34:2009 guidelines
This product is intended to be used as an analytical reference standard.
Bulk material is available for academic research at qualified institutions; please contact our sales department for pricing.
AM2201 4-methylnaphthyl analog
JWH 122 N-(5-fluoropentyl) analog.
AM2201 (Item No. 10707) is a potent synthetic cannabinoid (CB) which binds the CB1 and CB2 receptors with high affinity (Ki = 1.0 and 2.6 nM, respectively).
MAM2201 is an analog of AM2201 that is methylated at the 4 position of the naphthyl group. The physiological and toxicological properties of this compound have not been delineated.MAM-2201,eam-2201,how to make am-2201,am-2201 liquid,am-2201 legal status,am-2201 effects
This product is intended for research and forensic purposes.
This product is a qualified Reference Material (RM) that has been manufactured and tested to meet ISO17025 and Guide 34 guidelines.
These materials are tested using validated analytical methods on qualified instrumentation to ensure traceability of measurements.